I don't know if you felt it this morning, there was a light rumble, is what it seemed like to me,

or maybe it was the sound of the universe tearing wide open.

But what I'm telling you is right now, today, I believe we are marking a tipping point,

a tipping point in the change in the world as we know it, especially when

it comes to the pharmaceutical control of the world that we live in.

Of course, a lot of this revolves around a powerful Senate hearing today with Robert Kennedy

Jr. I have to say if you were watching, if you were tuned in the high wire, if you're

signed up to be one of the people on our mailing list, you were watching, if you were tuned in the highwire, if you're signed up to be

one of the people on our mailing list, you would have been told you could be watching this live

this morning. To say sparks were flying would be an understatement. To say that there were

forest fires, there were earthquakes, these are the moments that many of us have dreamed about

for a very long time.

To watch Robert Kennedy Jr., not trying to get a job, but standing firmly in a job

of removing all of the corporate controls inside of our regulatory agencies, dissolving all the

political controls that are taking place and getting back to science.

Standing his ground and telling the truth for the first time, it was epic, it was unbelievable.

But there was one moment that for many probably went unmist. I mean, it went, you know, unnoticed.

And ICANN actually has ventured into maybe one of the most ambitious projects we've ever taken on.

This is a project that is literally almost a decade in the making.

Let me point out that moment, and then we'll talk a little bit more about it.

This is Senator Ron Johnson in the hearing this morning with Robert F. Kennedy Jr.

We're going to be holding a hearing next Tuesday on a study done by a high integrity

...